Moisuc, D.C.; Constantinescu, D.; Marinca, M.V.; Gafton, B.; Pavel-Tanasa, M.; Cianga, P.
Cyclophilin A: An Independent Prognostic Factor for Survival in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab and Chemotherapy. Cancers 2024, 16, 385.
https://doi.org/10.3390/cancers16020385
AMA Style
Moisuc DC, Constantinescu D, Marinca MV, Gafton B, Pavel-Tanasa M, Cianga P.
Cyclophilin A: An Independent Prognostic Factor for Survival in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab and Chemotherapy. Cancers. 2024; 16(2):385.
https://doi.org/10.3390/cancers16020385
Chicago/Turabian Style
Moisuc, Diana Cornelia, Daniela Constantinescu, Mihai Vasile Marinca, Bogdan Gafton, Mariana Pavel-Tanasa, and Petru Cianga.
2024. "Cyclophilin A: An Independent Prognostic Factor for Survival in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab and Chemotherapy" Cancers 16, no. 2: 385.
https://doi.org/10.3390/cancers16020385
APA Style
Moisuc, D. C., Constantinescu, D., Marinca, M. V., Gafton, B., Pavel-Tanasa, M., & Cianga, P.
(2024). Cyclophilin A: An Independent Prognostic Factor for Survival in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab and Chemotherapy. Cancers, 16(2), 385.
https://doi.org/10.3390/cancers16020385